期刊文献+

萤光素酶表达质粒pEE14.1-luc的构建及表达

Construction and Expression of Recombinant Plasmid p EE14.1-luc
下载PDF
导出
摘要 目的:为研究10 kb以上DNA疫苗质粒的体内电穿孔递送,构建萤光素酶报告基因表达质粒p EE14.1-luc,并验证其表达。方法:从质粒p GL3-CMV中通过酶切、补平和纯化的方法获得萤光素酶基因luc,克隆入p EE14.1载体,构建重组表达质粒p EE14.1-luc,瞬时转染293T细胞,采用Western印迹、流式细胞术和免疫荧光等方法对萤光素酶基因在体外的表达情况进行验证,并运用活体成像仪检测萤光素酶基因在小鼠活体内的表达。结果:经菌液PCR鉴定和测序验证,p EE14.1-luc与预期设计完全一致;流式细胞术检测luc阳性表达率为22.41%,免疫荧光检测可见绿色荧光表达,Western印迹检测在相对分子质量为62×103处显现目的蛋白条带;同时,利用活体成像技术也检测到萤光素酶基因在小鼠活体内的表达。结论:p EE14.1-luc表达质粒构建成功,为研究DNA疫苗体内表达机制和体内电穿孔递送条件优化奠定了基础。 Objective: In order to study the delivery of DNA vaccine plasmid for over 10 kb by electroporation in vivo, we constructed the recombinant pEE14.1-luc, which can express the luciferase report gene. Methods: The luciferase gene was cut from pGL3-CMV vector, and inserted into pEE14.1-luc vector after filling in and purifica?tion. In vitro expression of the luciferase gene was identified by transient transfection to 293T cells, Western blot, flow cytometry and immunofluorescence. And in vivo expression of this gene was identified by in vivo imaging tech?nology. Results: The results indicated that pEE14.1-luc was constructed as we expected after the identification of microbial PCR and sequencing. The expression rate of luciferase was 22.41% tested by flow cytometry, and we could detect the expression of green fluorescence by immunofluorescence and a protein of 62 kD by Western blot. With in vivo imaging technology, we could also detect the expression of luciferase gene in mice in vivo. Conclu?sion: We conclude that pEE14.1-luc was successfully constructed, which lays a foundation for further studying the mechanism of in vivo expression of DNA vaccine and optimizing the in vivo conditions of delivery by electropora?tion.
出处 《生物技术通讯》 CAS 2014年第6期792-795,共4页 Letters in Biotechnology
基金 国家自然科学基金(31100655)
关键词 萤光素酶 pEE14.1载体 活体成像 luciferase pEE14.1 vector in vivo imaging
  • 相关文献

参考文献14

  • 1Ghanem A, Healey R, Adly F G. Current trends in separa- tion of plasmid DNA vaccines: a review[J]. Anal Chim Acta.2013,760:1-15.
  • 2Sardesai N Y, Weiner D B. Eleetrnporation delivery of DNA vaccines: prospects for success[J]. Curr Opin lmmunol, 2011,23 (3):421-429.
  • 3Gothelf A, Gehl J. What you always needed to know about electroporation based DNA vaccines[J]. Hum Vaccin Immunoth- er, 2012,8( 1 1 ): 1694-1702.
  • 4van Drunen Littel-van den Hurk S, Hannaman D. Electropora- tion fi)r DNA immunization: clinical application[J]. Exp Rev Vaccines. 2010,9(5):503-517.
  • 5李盼,张亮,王宇,朱晓明,张巍,徐元基,于继云,阎瑾琦.复制子荧光素酶表达质粒pSVK-luc的构建与应用[J].细胞与分子免疫学杂志,2013,29(7):765-768. 被引量:1
  • 6高燕,汪习,张巍,徐元基,于继云,郭炳冉,阎瑾琦.人干扰素α高效表达质粒pEE14.1-IFN-α的构建和表达[J].细胞与分子免疫学杂志,2012,28(4):381-383. 被引量:1
  • 7杨海,王芳宇.DNA疫苗的研究进展[J].中国畜牧兽医,2013,40(1):72-76. 被引量:16
  • 8Murakami T, Sunada Y. Plasmid DNA gene therapy by elec-troporation: principles and recent advances[J]. Curr Gene Ther, 2011,11(6):447-456.
  • 9Andre F, Mir L M. DNA electrotransfer:its principles and an updated reviewof its therapeutic applications[J]. Gene Ther, 2004,1 l(Suppl 1):33-42.
  • 10Wells D J. Gene therapy progess and prospects:electroporation and other physical metehods[J]. Gene Ther, 2004,11(18):1363- 1369.

二级参考文献74

  • 1李陕区,张惠中,杨博.拉米夫定联合重组乙肝疫苗治疗慢性乙型肝炎疗效观察[J].中国误诊学杂志,2005,5(6):1005-1007. 被引量:2
  • 2余云舟,孙志伟,刘志刚,俞炜源.基于DNA的Semliki森林病毒复制子载体体内外高水平表达外源基因[J].生物化学与生物物理进展,2006,33(1):87-94. 被引量:9
  • 3杜宇,樊明文,李宇红,郭继华,边专,陈智.防龋DNA疫苗pGJA-P/VAX免疫小鼠后的抗DNA抗体检测[J].口腔医学研究,2006,22(5):465-467. 被引量:9
  • 4Yuen MF,Lai CL.Treatment of chronic hepatitis B:Evolution overtwo decades[J].J Gastroenterol Hepatol,2011,Suppl 1:138-143.
  • 5Chen DS.Toward elimination and eradication of hepatitis B[J].JGastroenterol Hepatol,2010,25(1):19-25.
  • 6Hongthanakom,Lok AS.New pharmacologic therapies in chronicHepatitis B[J].Gastroenterol Clin North Am,2010,39(3):659-680.
  • 7Kilpatrick K,Kerner S,Dixon EP,et al.In vivo expression of a GST-fusion protein mediates the rapid generation of affinity matured mono-clonal antibodies using DNA-based immunizations[J].Hybrid Hybri-domics,2002,21(4):237-243.
  • 8Hollingshead MG, Bonomi CA, Borgel SD, et al. A potential role for imaging technology in anticancer efficacy evaluations[J]. Eur J Cancer, 2004,40(6) : 890-898.
  • 9Contag CH, Contag PR, Mullins JI, et al. Photonic detection of bacterial pathogens in living hosts [ J ]. Mol Microbiol, 1995, 18 (4):593-603.
  • 10Francis KP,Joh D, Bellinger-Kawahara C, et al. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel IuxABCDE construct[J]. Infect Immun,2000,68(6) :3594-3600.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部